An update from Allarity Therapeutics, Inc. (ALLR) is now available.
Allarity Therapeutics, Inc. has announced they’ve received additional time until May 14, 2024, to meet Nasdaq’s compliance requirements. This development offers the company a vital opportunity to address and rectify the issues concerning their listing status, providing shareholders and potential investors a renewed sense of confidence in the company’s ability to uphold financial market standards.
See more data about ALLR stock on TipRanks’ Stock Analysis page.
